Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Letter Commentary & Co-Mentions | Period / Date | Action |
|---|---|---|---|
“MaxCyte is a company with a manageable current burn rate, a leading position in ex-vivo gene editing equipment, and a series of current and hopefully future royalty streams associated with a number of drugs being developed with its equipment and consumables. Shares of MaxCyte...” | Q1 2026 Apr 29, 2026 | Preview | |
“RGA Investment Advisors made strategic portfolio adjustments in Q1 2024, trimming their large Meta position to fund increased investments in life sciences companies. They substantially increased...” | Q4 2023 May 23, 2024 | Preview |
Read unredacted commentary excerpts, portfolio weight disclosures, and high-conviction theses from hedge fund managers discussing $MXCT.
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
